PledPharma AB (publ) Stock Nasdaq Stockholm
Stocks
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 09-20 | Egetis Therapeutics AB(OM:EGTX) added to S&P Global BMI Index | CI |
| 09-16 | Egetis Therapeutics AB Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 01:50 PM |
| Market Cap | 3.62B 365M 321M 302M 276M 515M 35.01B 519M 1.4B 17.85B 1.37B 1.34B 57.87B | P/E 2026 * |
-8.95x | P/E 2027 * | -17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.07B 310M 272M 256M 234M 437M 29.68B 440M 1.19B 15.13B 1.16B 1.14B 49.06B | EV / Sales 2026 * |
5.57x | EV / Sales 2027 * | 9.97x |
| Free-Float |
37.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: PledPharma AB (publ)
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2017-06-15 | |
Yilmaz Mahshid
DFI | Director of Finance/CFO | 47 | 2017-12-30 |
Tiago Nune
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2016-12-31 | |
Mats Blom
CHM | Chairman | 61 | 2024-05-05 |
Behshad Sheldon
BRD | Director/Board Member | 63 | 2022-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | +6.49% | +60.29% | +111.13% | 74.18B | |
| -2.29% | -1.51% | +33.30% | +75.07% | 59.55B | |
| -2.05% | -3.46% | -18.60% | +352.20% | 25.84B | |
| -2.39% | +2.74% | +0.19% | -5.91% | 24.73B | |
| +0.57% | +3.66% | +25.59% | -9.37% | 20.87B | |
| +1.29% | -2.49% | +152.11% | +333.06% | 15.32B | |
| -2.44% | -0.09% | +42.50% | +164.11% | 14.06B | |
| -3.91% | -4.91% | -14.10% | +779.68% | 13.12B | |
| -1.12% | -3.04% | +15.72% | +234.56% | 11.85B | |
| Average | -1.36% | -0.40% | +33.00% | +226.06% | 28.84B | |
| Weighted average by Cap. | -1.20% | +0.70% | +36.38% | +161.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 551M 55.61M 48.81M 45.88M 41.94M 78.38M 5.33B 78.96M 214M 2.72B 209M 204M 8.8B | 328M 33.08M 29.03M 27.29M 24.95M 46.62M 3.17B 46.97M 127M 1.62B 124M 121M 5.24B |
| Net income | 161M 16.27M 14.28M 13.43M 12.28M 22.94M 1.56B 23.11M 62.52M 795M 61.11M 59.77M 2.58B | -134M -13.55M -11.89M -11.18M -10.22M -19.09M -1.3B -19.24M -52.04M -662M -50.87M -49.76M -2.15B |
| Net Debt | -552M -55.67M -48.87M -45.93M -42M -78.48M -5.33B -79.06M -214M -2.72B -209M -204M -8.82B | -353M -35.63M -31.27M -29.39M -26.87M -50.22M -3.41B -50.59M -137M -1.74B -134M -131M -5.64B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
